RAAPID Secures Series A Funding from Microsoft's M12 to Transform Healthcare Risk Adjustment with AI

RAAPID, a Louisville-based healthcare technology company, has secured Series A funding from M12, Microsoft Venture Fund, to expand deployment of its AI-powered risk adjustment solutions. The investment addresses the significant challenge of processing unstructured medical data, which comprises over 70% of medical records and often leads to coding errors and inconsistent reimbursement capture.

The company's proprietary VisionAI technology ingests, normalizes, and converts both structured and unstructured data into machine-readable formats, enabling healthcare organizations to better manage prospective risk adjustment and value-based care initiatives. This AI-powered solution streamlines pre-visit analysis and retrospective reviews, helping organizations optimize their risk adjustment programs while reducing chart review time by over 60% and maintaining 95% coding accuracy.

RAAPID's technology serves organizations participating in Medicare Advantage, ACA, Medicare ACO, and health systems, integrating with existing electronic health record systems to improve operational efficiency in data processing and analysis. The platform focuses on enhancing coding compliance, reducing errors, and optimizing return on investment for healthcare organizations navigating the complexities of value-based care arrangements.

The investment from Microsoft's venture arm validates RAAPID's mission to transform risk adjustment through purpose-built AI technology and provides access to Microsoft's broader ecosystem, potentially accelerating market expansion in the healthcare risk adjustment space. This funding signals continued momentum in developing AI applications for healthcare administration and risk management, reflecting growing venture capital interest in solutions that address the industry's shift toward value-based care models.